| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.06. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 03.06. | Work Medical establishes U.S. subsidiary in Nevada | 3 | Investing.com | ||
| 03.06. | WORK Medical Technology Group LTD: WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy | 1 | GlobeNewswire (USA) | ||
| 27.05. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 14.05. | Morning Market Movers: Robo.ai, Antelope Enterprise Holdings, WORK Medical Technology Group, POET Technologies See Big Swings | 963 | AFX News | SAN FRANCISCO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the... ► Artikel lesen | |
| 13.05. | WORK Medical Technology Group Is Trending Overnight - Here's Why WOK Stock Surged Over 69% In After-Hours Session | 19 | Benzinga.com | ||
| 11.05. | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | 19 | GlobeNewswire (USA) | ||
| 01.05. | WORK Medical Technology Group LTD: WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | 1 | GlobeNewswire (USA) | ||
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 15.04. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | WORK Medical Technology Group LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 30.12.25 | Work Medical Technology Group schließt Aktienzusammenlegung im Verhältnis 100:1 ab | 5 | Investing.com Deutsch | ||
| 30.12.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | WORK Medical Shares Jump 9% On Exclusive AI Blood Analysis Deal In China | 1 | RTTNews | ||
| 29.12.25 | WORK Medical Signs East China Distribution Deal For AI Blood Analyzer, Stock Up | 1 | RTTNews | ||
| 29.12.25 | Produktionszulassung für KI-Blutanalysegerät beflügelt Aktie von WORK Medical | 2 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical subsidiary signs exclusive distribution deal for blood analyzer | 1 | Investing.com | ||
| 29.12.25 | WORK Medical schließt exklusiven Vertriebsvertrag für KI-Blutanalysegerät in Ostchina | - | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 543 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,222 | -1,98 % | Fair-Value-Analyse prognostizierte Kursrallye: Teladoc-Aktie legt um 69 % zu | ||
| HIMS & HERS HEALTH | 23,460 | +1,12 % | HIMS & HERS HEALTH INC zeigt strukturelle Stärke | ||
| PLUS THERAPEUTICS | 4,585 | +0,22 % | Plus Therapeutics Inc.: Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ Clinical Program and CNSide Commercial Rollout | HOUSTON, May 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| HEALWELL AI | 0,490 | -2,20 % | HEALWELL verzeichnet im 1. Quartal 2026 eine Umsatzsteigerung von 316 % und verbessert die Kundenbindung | - HEALWELL erzielte im ersten Quartal 2026 einen Quartalsumsatz aus fortlaufender Betriebstätigkeit in Höhe von 33,2 Millionen $, was einem Anstieg um 316 % gegenüber dem im
ersten Quartal... ► Artikel lesen | |
| ORGANON | 11,605 | 0,00 % | Organon & Co. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 4,140 | -3,50 % | Co-Diagnostics sichert sich Exklusivvertrieb in Mexiko | ||
| VERU | 3,010 | +0,33 % | Veru-Aktie im Aufwind: Deal mit Novo Nordisk beflügelt Kurs um über 10 % | ||
| CLOVER HEALTH INVESTMENTS | 4,090 | 0,00 % | Clover Health gets Medicare Star Rating upgrade | ||
| SENSEONICS | 6,550 | +5,65 % | Senseonics, Welldoc partner on next-gen Eversense 365 app development | ||
| ELEKTA | 4,842 | +0,41 % | Elekta AB: Year-end report May-April 2025/26 | Fourth quarterIn constant exchange rates, net sales decreased by 1 percent mainly driven by APAC, despite growth in China. Reported sales in SEK decreased by 8 percent amounting to SEK 4,762 M (5,156).Fourth... ► Artikel lesen | |
| IMUNON | 1,710 | 0,00 % | Imunon, Inc.: IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study | IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,470 | +0,24 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-a-NET in the Meningioma Cohort of a Phase 1/2a Study | SEATTLE, June 03, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| AXOGEN | 36,480 | 0,00 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,705 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| AXE COMPUTE | 5,800 | -6,45 % | Axe Compute Inc. - 8-K, Current Report |